ABSTRACT
Allergic reactions (sic) (1984): Steffan MA+, Contact Dermatitis 10, 184 Erythema multiforme (<1%) (2002): Krivo JM, Franklin Square, NY (from Internet) (observation) (1979): Pollack MA+, Ann Neurol 5, 262 (1975): Böttiger LE+, Acta Med Scand 198, 229 Exanthems (1-5%) (1980): Marghescu S+, Fortschr Med (German) 98, 723 Exfoliative dermatitis Lupus erythematosus (<1%) (1994): Yung RL+, Rheum Dis Clin North Am 20, 61 (1993): Drory VE+, Clin Neuropharmacol 16, 19 (passim) (1980): Condemi JJ, Geriatrics 35(3), 81 (1977): Schubothe H+, Verh Dtsch Ges Inn Med (German) 83, 727 (1972): Levantine A+, Br J Dermatol 87, 646 (passim) (1966): Ahuja GK+, JAMA 198, 201 Rash (sic) (<1%) Toxic epidermal necrolysis (1985): Muhar U+, Pediatr Dermatol 3, 54 (1979): Pollack MA+, Ann Neurol 5, 262 (1973): Stüttgen G, Br J Dermatol 88, 291 (1970): Hermann WA, Dermatologica 141, 366 Urticaria (1984): Steffan MA+, Contact Dermatitis 10, 184
Other Acute intermittent porphyria
Gingival hyperplasia Hypersensitivity* (2002): Krivo JM, Franklin Square, NY (from Internet) (observation) (1998): Schlienger RG+, Epilepsia 39, S3 (passim) Mucocutaneous syndrome (1975): Böttiger LE+, Acta Med Scand 198, 229 Rhabdomyolysis (1990): Larpin R+, Presse Med 19(30), 1403
*Note: The antiepileptic drug hypersensitivity syndrome is a severe, occasionally fatal, disorder characterized by any or all of the following: pruritic exanthems, toxic epidermal necrolysis, Stevens-Johnson syndrome, exfoliative dermatitis, fever, hepatic abnormalities, eosinophilia, and renal failure
